The surgical robotics developer received $78.3m in funding from investors including New World Development, Lilly Asia Ventures and Meituan's DragonBall Capital fund.

China-based medical robotics developer Cornerstone Robotics has closed a RMB500m ($78.3m) series B round featuring pharmaceutical firm Eli Lilly, property developer New World Development and local services portal Meituan, DealStreetAsia reported yesterday. Private equity firm Tsing Song Capital and venture capital firms Gaorong Capital, Qiming Venture Partners and K2VC filled out the participants in the…

The rest of this content is only accessible to Global Corporate Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.